Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib for Duodenal Polyps in FAP
NCT00844727Phase 3Terminated
- Sponsor
- Oslo University Hospital
- Start
- Sep 2003
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rofecoxib in familial adenomatous polyposis (FAP), sponsored by Oslo University Hospital. Started Sep 2003; status: terminated.
02
Drugs
rofecoxib
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT00844727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844727.